Combined Calcium and Vitamin D3 Supplementation in Elderly Women: Confirmation of Reversal of Secondary Hyperparathyroidism and Hip Fracture Risk: The Decalyos II Study

Vitamin D insufficiency and low calcium intake contribute to increase parathyroid function and bone fragility in elderly people. Calcium and vitamin D supplements can reverse secondary hyperparathyroidism thus preventing hip fractures, as proved by Decalyos I. Decalyos II is a 2-year, multicenter, randomized, double-masked, placebo-controlled confirmatory study. The intention-to-treat population consisted of 583 ambulatory institutionalized women (mean age 85.2 years, SD = 7.1) randomized to the calcium–vitamin D3 fixed combination group (n= 199); the calcium plus vitamin D3 separate combination group (n= 190) and the placebo group (n= 194). Fixed and separate combination groups received the same daily amount of calcium (1200 mg) and vitamin D3 (800 IU), which had similar pharmacodynamic effects. Both types of calcium-vitamin D3 regimens increased serum 25-hydroxyvitamin D and decreased serum intact parathyroid hormone to a similar extent, with levels returning within the normal range after 6 months. In a subgroup of 114 patients, femoral neck bone mineral density (BMD) decreased in the placebo group (mean =–2.36% per year, SD = 4.92), while remaining unchanged in women treated with calcium-vitamin D3 (mean = 0.29% per year, SD = 8.63). The difference between the two groups was 2.65% (95% CI =–0.44, 5.75%) with a trend in favor of the active treatment group. No significant difference between groups was found for changes in distal radius BMD and quantitative ultrasonic parameters at the os calcis. The relative risk (RR) of HF in the placebo group compared with the active treatment group was 1.69 (95% CI = 0.96, 3.0), which is similar to that found in Decalyos I (RR = 1.7; 95% CI = 1.0, 2.8). Thus, these data are in agreement with those of Decalyos I and indicate that calcium and vitamin D3 in combination reverse senile secondary hyperparathyroidism and reduce both hip bone loss and the risk of hip fracture in elderly institutionalized women.

[1]  M. Hakama,et al.  Prostate cancer risk and prediagnostic serum 25-hydroxyvitamin D levels (Finland) , 2000, Cancer Causes & Control.

[2]  M. Holick,et al.  Aging Decreases the Capacity of Human Skin to Produce Vitamin D3 , 1986 .

[3]  G. Schwartz,et al.  Geographic patterns of prostate cancer mortality. Evidence for a protective effect of ultraviolet radiation , 1992, Cancer.

[4]  H. DeLuca,et al.  Intestinal calcium absorption and serum vitamin D metabolites in normal subjects and osteoporotic patients: effect of age and dietary calcium. , 1979, The Journal of clinical investigation.

[5]  R. Utiger.  The need for more vitamin D. , 1998, The New England journal of medicine.

[6]  A M Schott,et al.  Effects of a New Positioner on the Precision of Hip Bone Mineral Density Measurements , 1997, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[7]  D. Hosking,et al.  Vitamin D insufficiency increases bone turnover markers and enhances bone loss at the hip in patients with established vertebral osteoporosis , 1999, Clinical endocrinology.

[8]  A. Black,et al.  Relative contributions of diet and sunlight to vitamin D state in the elderly. , 1979, British medical journal.

[9]  R. Boland.  Role of vitamin D in skeletal muscle function. , 1986, Endocrine reviews.

[10]  M. Chapuy,et al.  Age-related changes in parathyroid hormone and 25 hydroxycholecalciferol levels. , 1983, Journal of gerontology.

[11]  H. van den Berg,et al.  Serum vitamin D concentrations among elderly people in Europe , 1995, The Lancet.

[12]  J. Fordtran,et al.  Effect of dietary calcium and age on jejunal calcium absorption in humans studied by intestinal perfusion. , 1973, The Journal of clinical investigation.

[13]  S Senn,et al.  Analysis of serial measurements in medical research. , 1990, BMJ.

[14]  C. Garland,et al.  Can colon cancer incidence and death rates be reduced with calcium and vitamin D? , 1991, The American journal of clinical nutrition.

[15]  P. Garnero.  Markers of Bone Turnover for the Prediction of Fracture Risk , 2000, Osteoporosis International.

[16]  M. Holick,et al.  Redefining vitamin D insufficiency , 1998, The Lancet.

[17]  H. Glerup,et al.  Hypovitaminosis D Myopathy Without Biochemical Signs of Osteomalacic Bone Involvement , 2000, Calcified Tissue International.

[18]  M. McKenna,et al.  Differences in vitamin D status between countries in young adults and the elderly. , 1992, The American journal of medicine.

[19]  J. Goodwin,et al.  Nutritional status in a healthy elderly population: vitamin D. , 1982, The American journal of clinical nutrition.

[20]  D. Felsenberg,et al.  Alendronate Increases Bone Density and Bone Strength at the Distal Radius in Postmenopausal Women , 1999, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[21]  P. Delmas,et al.  Healthy elderly French women living at home have secondary hyperparathyroidism and high bone turnover in winter. EPIDOS Study Group. , 1996, The Journal of clinical endocrinology and metabolism.

[22]  J. Gallagher,et al.  Effect of age on calcium absorption. , 1970, Lancet.

[23]  Barrett T. Kitch,et al.  Hypovitaminosis D in medical inpatients. , 1998, The New England journal of medicine.

[24]  P. Delmas,et al.  The effect of vitamin D supplementation on vitamin D status and parathyroid function in elderly subjects. , 1988, The Journal of clinical endocrinology and metabolism.

[25]  H. Glerup,et al.  Commonly recommended daily intake of vitamin D is not sufficient if sunlight exposure is limited , 2000, Journal of internal medicine.

[26]  E. Kaplan,et al.  Nonparametric Estimation from Incomplete Observations , 1958 .

[27]  R. Kumar,et al.  Impaired vitamin D metabolism with aging in women. Possible role in pathogenesis of senile osteoporosis. , 1984, The Journal of clinical investigation.

[28]  G E Dallal,et al.  Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older. , 1997, The New England journal of medicine.

[29]  L. Bouter,et al.  Vitamin D Supplementation and Fracture Incidence in Elderly Persons , 1996, Annals of Internal Medicine.

[30]  K. Ishibashi,et al.  1,25(OH)2D3 modulates intracellular Ca2+ and force generation in resistance arteries. , 1996, The American journal of physiology.

[31]  B. Boucher,et al.  Vitamin D status of residents of an old people's home and long-stay patients. , 1979, Gerontology.

[32]  François Duboeuf,et al.  Vitamin D3 and Calcium to Prevent Hip Fractures in Elderly Women , 1993 .

[33]  J. Compston.  Vitamin D deficiency: time for action , 1998, BMJ.

[34]  P. Galan,et al.  Prevalence of Vitamin D Insufficiency in an Adult Normal Population , 1997, Osteoporosis International.

[35]  M. Chapuy,et al.  Effect of calcium and cholecalciferol treatment for three years on hip fractures in elderly women , 1994, BMJ.